P. Jansen

发表

Practical Problems with Medication Use that Older People Experience: A Qualitative Study

K. Notenboom, E. Beers, D. V. van Riet-Nales, 2014, Journal of the American Geriatrics Society.

Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly.

P. Jansen, B. Schulte, F. Gribnau, 1986, British medical journal.

Blood Pressure Reduction After the First Dose of Captopril and Perindopril

P. Jansen, O. J. de Vries, Sophia E. J. A. De Rooy, 2001, Journal of the American Geriatrics Society.

The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics

A. Egberts, M. Ribbe, P. Jansen, 2009, International Psychogeriatrics.

Risk of cerebrovascular events in elderly users of antipsychotics

A. Egberts, P. Jansen, R. V. van Marum, 2009, Journal of psychopharmacology.

Statin Prescribing in the Elderly in the Netherlands

P. Jansen, T. Schalekamp, A. Mantel‐Teeuwisse, 2010, Drugs & aging.

Off-Label Prescribing in Older Patients

P. Jansen, A. Mangoni, S. Jackson, 2012, Drugs & Aging.

Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic review

T. Egberts, P. Jansen, R. V. van Marum, 2013, Therapeutic advances in drug safety.

STRIPA: A Rule-Based Decision Support System for Medication Reviews in Primary Care

Sjaak Brinkkemper, Michiel Meulendijk, Paul Jansen, 2015, ECIS.

Antihypertensive treatment as a possible cause of stroke in the elderly.

R. Meyboom, P. Jansen, B. Schulte, 1986, Age and ageing.

Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: A systematic review

T. Egberts, P. Jansen, R. Marum, 2013, Ageing Research Reviews.

Reasons for discontinuation of medication during hospitalization and documentation thereof: a descriptive study of 400 geriatric and internal medicine patients.

T. Egberts, P. Jansen, R. V. van Marum, 2010, Archives of internal medicine.

An observational, retrospective study of the length of stay, and its influencing factors, among elderly patients at the Emergency Department

P. Jansen, S. Vermeer, D. Taekema, 2015 .

Appropriate use of diuretics: an opportunity to optimise drug treatment in the elderly.

P. Jansen, 1998, The Netherlands journal of medicine.

Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients

T. Egberts, P. Jansen, E. Heerdink, 2010, Journal of clinical psychopharmacology.

Parkinsonism in Elderly Users of Haloperidol: Associated With Dose, Plasma Concentration, and Duration of Use

T. Egberts, P. Jansen, R. V. van Marum, 2012, Journal of clinical psychopharmacology.

Quality of life of elderly patients with antipsychotic-induced parkinsonism: a cross-sectional study.

T. Egberts, P. Jansen, R. V. van Marum, 2012, Journal of the American Medical Directors Association.

Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?

R. Roos, P. Jansen, A. Porsius, 2004, Pharmacy World and Science.

Adherence with Dosing Guideline in Patients with Impaired Renal Function at Hospital Discharge

T. Egberts, P. Jansen, R. V. van Marum, 2015, PloS one.

Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement

E. Grove, P. Vestergaard, H. Leufkens, 2013, Journal of thrombosis and haemostasis : JTH.

Antipsychotic Drug Use and Risk of Pneumonia in Elderly People

A. Egberts, P. Jansen, R. V. van Marum, 2008, Journal of the American Geriatrics Society.

Education on prescribing for older patients in the Netherlands: a curriculum mapping

P. Jansen, C. Keijsers, J. Tichelaar, 2015, European Journal of Clinical Pharmacology.

Quick Titration of Pergolide in Cotreatment with Domperidone Is Safe and Effective

R. Herings, P. Jansen, T. van Laar, 2001, Clinical neuropharmacology.

Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids.

P. Jansen, E. V. van Roon, J. Brouwers, 2012, Drugs & aging.

Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment

R. Roos, P. Jansen, A. Porsius, 2002, European Journal of Clinical Pharmacology.

Criteria for Drug Selection in Frail Elderly Persons

P. Jansen, R. Marum, E. Roon, 2011, Drugs & aging.

Cerebral ischaemia and stroke as side effects of antihypertensive treatment; special danger in the elderly. A review of the cases reported in the literature.

P. Jansen, B. Schulte, F. Gribnau, 1987, The Netherlands journal of medicine.

Validity and reliability of the Simpson‐Angus Scale (SAS) in drug induced parkinsonism in the elderly

A. Egberts, P. Jansen, C. Keijsers, 2009, International journal of geriatric psychiatry.

Effect of a Program of Diverse Activities on Disturbed Behavior in Three Severely Demented Patients

P. Jansen, R. Vingerhoets, R. Sival, 1997, International Psychogeriatrics.

Muscle strength, functional mobility and vitamin D in older women

P. Jansen, M. Samson, H. Verhaar, 2000, Aging.

Prescribing for Elderly Patients

P. Jansen, A. Mangoni, S. Jackson, 1987 .

Lithium augmentation in geriatric depression.

W. Nolen, P. Jansen, W. Hop, 1990, Journal of affective disorders.

Inﬂuence of benzodiazepines on antiparkinsonian drug treatment in levodopa users of benzodiazepines on antiparkinsonian drug treatment in users.

P. Jansen, A. Porsius, A. Boer, 2001 .

Abstracts of papers clinical pharmacological meeting

D. J. Veldhuisen, J. Remon, J. Ottervanger, 2005, Pharmacy World and Science.

Use of antipsychotics in Parkinson's disease in daily practice

R. Roos, P. Jansen, A. Porsius, 2002 .

Authors' Reply

R. Roos, H. Leufkens, P. Jansen, 2002 .

Sodium valproate in the treatment of aggressive behavior in patients with dementia—a randomized placebo controlled clinical trial

P. Jansen, P. Eikelenboom, S. Duursma, 2002, International journal of geriatric psychiatry.

THE EFFECTS OF SODIUM VALPROATE ON DISTURBED BEHAVIOR IN DEMENTIA

P. Jansen, R. Sival, P. Haffmans, 1994, Journal of the American Geriatrics Society.

Diagnostic errors; the need to have autopsies.

P. Jansen, C. M. Aalten, M. Samson, 2006, The Netherlands journal of medicine.

Abstracts of Dutch doctoral theses

P. Jansen, R. Driebergen, J. Zijlstra, 2005, Pharmaceutisch Weekblad.

Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol.

P. Jansen, P. van Mierlo, Amir I. A. Ahmed, 2010, General hospital psychiatry.

Effect of a Discharge Medication Intervention on the Incidence and Nature of Medication Discrepancies in Older Adults

T. Egberts, P. Jansen, R. Marum, 2013, Journal of the American Geriatrics Society.

Clinical Pharmacology in Old Persons

P. Jansen, J. Brouwers, 2012, Scientifica.

Renal function assessment in older adults.

J. Proost, T. Egberts, P. Jansen, 2013, British journal of clinical pharmacology.

Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study.

T. Egberts, P. Jansen, R. Kok, 2013, Maturitas.

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) or Hyponatraemia Associated with Valproic Acid

P. Jansen, I. Bartelink, E. Puijenbroek, 2010, Drug safety.

Hyponatraemia as an Adverse Drug Reaction of Antipsychotic Drugs

T. Egberts, P. Jansen, R. Marum, 2010, Drug safety.

[Hallucinations and vivid dreams by use of metoprolol].

P. Jansen, J. V. van Waarde, P. van Mierlo, 2010, Tijdschrift voor psychiatrie.

Pharmacokinetic and pharmacodynamic studies in older adults

P. Jansen, A. Mangoni, S. Jackson, 2016 .

Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine

M. Postma, J. Maring, P. Jansen, 2019, Journal of clinical psychopharmacology.

Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)

M. Postma, J. Maring, P. Jansen, 2015, Trials.

Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case–control study using spontaneous reports

P. Jansen, E. V. van Puijenbroek, A. de Boer, 2002, International clinical psychopharmacology.

Systematic Evaluation of Rating Scales for Drug-Induced Parkinsonism and Recommendations for Future Research

P. Jansen, C. Keijsers, R. V. van Marum, 2010, Journal of clinical psychopharmacology.

Antipsychotic-Induced Hyponatraemia

T. Egberts, P. Jansen, D. Meulendijks, 2010, Drug safety.

1 Clinical pharmacology of ageing

P. Jansen, A. Mangoni, S. Jackson, 2009 .

Age and the Process of Aging

P. Jansen, 2016 .

Participation of Older People in Preauthorization Trials of Recently Approved Medicines

E. Beers, T. Egberts, H. Leufkens, 2014, Journal of the American Geriatrics Society.

Variability between nursing homes in prevalence of antipsychotic use in patients with dementia

A. Egberts, M. Ribbe, P. Jansen, 2013, International Psychogeriatrics.

Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.

R. Roos, P. Jansen, A. Porsius, 2002, British journal of clinical pharmacology.

Treatment of Chronic Pain in Older People

P. Jansen, E. Roon, J. Brouwers, 2012, Drugs & Aging.

Priority Medicines for Europe and the World " A Public Health Approach to Innovation " Update on 2004

P. Jansen, A. Mantel‐Teeuwisse, L. Martial, 2013 .

Under-representation of older adults in pharmacokinetic and pharmacodynamic studies: a solvable problem?

P. Jansen, A. Mangoni, S. Jackson, 2013, Expert review of clinical pharmacology.

Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users

R. Roos, P. Jansen, A. Porsius, 2002, Acta neurologica Scandinavica.

Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study.

R. Roos, H. Leufkens, P. Jansen, 2002, Pharmacogenetics.

Recurrence of Adverse Drug Reactions following Inappropriate Re-Prescription

A. Egberts, P. Jansen, R. Grouls, 2010, Drug safety.

Efficiency of Clinical Decision Support Systems Improves with Experience

Sjaak Brinkkemper, Michiel Meulendijk, Paul Jansen, 2016, Journal of Medical Systems.

Pharmacokinetics of high-dosage naproxen in elderly patients.

P. Jansen, C. V. van Ginneken, F. A. van den Ouweland, 1988, International journal of clinical pharmacology, therapy and toxicology.

Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study

T. Egberts, P. Jansen, E. Heerdink, 2012, Heart.

Risk of Extrapyramidal Syndromes with Haloperidol, Risperidone, or Olanzapine

R. Roos, R. Herings, H. Leufkens, 2001, The Annals of pharmacotherapy.

Use of a Structured Medication History to Establish Medication Use at Admission to an Old Age Psychiatric Clinic: A Prospective Observational Study

P. Jansen, R. Kok, A. C. Drenth-van Maanen, 2013, CNS Drugs.

Structured History Taking of Medication Use Reveals Iatrogenic Harm Due to Discrepancies in Medication Histories in Hospital and Pharmacy Records

T. Egberts, P. Jansen, R. Marum, 2011, Journal of the American Geriatrics Society.

POLYPHARMACY AND UNDERPRESCRIBING IN OLDER ADULTS: RATIONAL UNDERPRESCRIBING BY GENERAL PRACTITIONERS

P. Jansen, M. Los, R. V. van Marum, 2011, Journal of the American Geriatrics Society.

Changes in Under-Treatment after Comprehensive Geriatric Assessment

J. Beijnen, P. Jansen, L. Tulner, 2010, Drugs & aging.

Course of blood pressure after cerebral infarction and transient ischemic attack

P. Jansen, B. Schulte, P. Jansen, 1987, Clinical Neurology and Neurosurgery.

Introducing the CORETEST feasibility analysis in medical informatics: a case study of a decision-supportive knowledge system in the Dutch primary care sector

Sjaak Brinkkemper, Mattijs E. Numans, Marco Spruit, 2013 .

An Electronic System to Document Reasons for Medication Discontinuation and to Flag Unwanted Represcriptions in Geriatric Patients

T. Egberts, P. Jansen, R. Grouls, 2012, Drugs & Aging.

Represcription after adverse drug reaction in the elderly: a descriptive study.

A. Egberts, P. Jansen, H. Maas, 2006, Archives of internal medicine.

Effect of a Transitional Pharmaceutical Care Intervention at Hospital Discharge on Registration of Changes in Medication Regimens in Primary Care

T. Egberts, P. Jansen, R. Marum, 2014, Journal of the American Geriatrics Society.

Structured Pharmaceutical Analysis of the Systematic Tool to Reduce Inappropriate Prescribing Is an Effective Method for Final‐Year Medical Students to Improve Polypharmacy Skills: A Randomized Controlled Trial

P. Jansen, C. Keijsers, D. J. Wildt, 2014, Journal of the American Geriatrics Society.

Antipsychotic-induced extrapyramidal syndromes

R. Roos, P. Jansen, A. Boer, 2001, European Journal of Clinical Pharmacology.

Genetic Variation and the Risk of Haloperidol-Related Parkinsonism in Elderly Patients: A Candidate Gene Approach

R. Ophoff, E. Strengman, T. Egberts, 2013, Journal of clinical psychopharmacology.

Sodium valproate in aggressive behaviour in dementia: a twelve‐week open label follow‐up study

P. Jansen, H. Duivenvoorden, P. Eikelenboom, 2004, International journal of geriatric psychiatry.

[Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].

P. Jansen, R. V. van Marum, 2005, Nederlands tijdschrift voor geneeskunde.

[Clinically relevant drug interactions in the elderly].

P. Jansen, 2003, Nederlands tijdschrift voor geneeskunde.

Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records

P. Jansen, A. Porsius, A. de Boer, 2001, Pharmacoepidemiology and drug safety.